查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1124829

基因測序的全球市場 (～2027年):各核苷酸排列、技術、用途、終端用戶、地區的競爭預測、機會

Global Genome Sequencing Market, By Nucleotide Sequenced, By Technique, By Application, By End User, By Region Competition Forecast and Opportunities, 2027
出版日期: | 出版商: TechSci Research | 英文 111 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球基因測序的市場由於遺傳基因定序和生物資訊學技術的進步高漲的背景，在預測期間內預計以高年複合成長率成長。

對先進醫藥品的需求劇增和感染疾病進化預計更加促進今後5年的市場成長。還有來自政府的穩定資金供給和技術研究範圍的擴大也支持今後5年的市場成長。再加上癌症的罹患率增加和癌症研究中新一代定序用途增加，基因產業上新業務和Start-Ups企業的進入等也顯示進一步市場成長的機會。

本報告提供全球基因測序的市場調查，市場概要，市場規模的變化、預測，各種區分、各地區/主要國家的明細，市場的各種影響因素的分析，競爭環境，市場佔有率，主要企業簡介等彙整資訊。

目錄

第1章 產品概要

第2章 調查手法

第3章 摘要整理

第4章 COVID-19:對全球基因測序市場的影響

第5章 VOC (客戶的迴響)

第6章 全球基因測序市場預測

  • 市場規模、預測
  • 市場佔有率、預測
    • 各核苷酸排列(DNA、RNA)
    • 各技術(次世代定序、PCR、微陣列技術、其他)
    • 各用途(診斷、藥物研發&開發、精密醫療、其他)
    • 各終端用戶(學術&研究機關、製藥&生物科技企業、醫院&診療所、其他)
    • 各企業
    • 各地區
  • 產品市場地圖

第8章 北美的基因測序市場預測

  • 市場規模、預測
  • 市場佔有率、預測
    • 各核苷酸排列
    • 各技術
    • 各用途
    • 各終端用戶
    • 各國
  • 各國分析

第8章 歐洲的基因測序市場預測

  • 市場規模、預測
  • 市場佔有率、預測
    • 各核苷酸排列
    • 各技術
    • 各用途
    • 各終端用戶
    • 各國
  • 各國分析

第9章 亞太地區的基因測序市場預測

  • 市場規模、預測
  • 市場佔有率、預測
    • 各核苷酸排列
    • 各技術
    • 各用途
    • 各終端用戶
    • 各國
  • 各國分析

第10章 南美的基因測序市場預測

  • 市場規模、預測
  • 市場佔有率、預測
    • 各核苷酸排列
    • 各技術
    • 各用途
    • 各終端用戶
    • 各國
  • 各國分析

第11章 中東及非洲的基因測序市場預測

  • 市場規模、預測
  • 市場佔有率、預測
    • 各核苷酸排列
    • 各技術
    • 各用途
    • 各終端用戶
    • 各國
  • 各國分析

第12章 市場動態

  • 促進因素
  • 課題

第13章 市場趨勢、市場展開

第14章 競爭情形

  • 企業簡介
  • Thermo Fisher Scientific, Inc.
  • Ilumina, Inc.
  • QIAGEN N.V.
  • Eurofins Scientific SE
  • Agilent Technologies, Inc.
  • Oxford Nanopore Technologies Limited
  • F. Hoffmann-La Roche AG
  • Bio-Rad Laboratories, Inc.
  • Abbott Laboratories, Inc.
  • Danaher Corporation

第15章 策略性建議

簡介目錄
Product Code: 10656

Global genome sequencing market is anticipated to grow with an impressive CAGR during the forecast years on the grounds of growing technological advancement in genetic sequencing and bioinformatics. Surge in the demand for the advanced pharmaceuticals and evolving infectious diseases further drive the growth of the global genome sequencing market in the upcoming five years. With consistent supply of financial funds from the government and higher research scope in the technology also supports the growth of the global genome sequencing market in the next five years. Moreover, growing instances of cancer and increasing applications of next generation sequencing in cancer research, the entry of new players and start-ups in the genomics industry further substantiates the growth of the global genome sequencing market in the forecast years.

Genome sequencing is a form of genetic engineering tool that can be defined as the method of identification and analysis of the genetic material found in any living organisms. Sequencing is basically identifying the DNA or RNA mapping sequences to diagnose the function of the translated protein and its effect on the organisms. The genome sequencing helps in identifying the threat or the properties of the evolution of the organisms. The process becomes highly apt for the healthcare processes where identification of the disease causing microorganisms can be carried out and design effective pharmaceutical and therapeutics along with precision medicine to treat these diseases.

Pharmaceutical Evolution Drives Market Growth

Increasing instances of infectious diseases and surge in the demands for the effective vaccinations and pharmaceutical products actively drive the growth of the global genome sequencing market in the upcoming five years. Application of genome sequencing for drug discovery and development increased in the recent years owing to the pandemic conditions caused due to viral infection of COVID-19. Sudden demand for the vaccination and treatment pharmaceuticals and therapeutics further aided to the growth of the global genome sequencing market in the future five years.

Detailed study on the genome (RNA) of the SARS-CoV-2 virus was conducted and multiple market players with the financial aids from the government discovered effective vaccine against the infection. High investments, reliability of the procedure, along with the threat of lost lives due to COVID-19 played major role in the recent developments in the genome sequencing thereby substantiating the growth of the global genome sequencing market in the forecast years. Government authorities like National Institutes for Health in the United States invested USD4435 Million in total human genome project that would be utilized for the further advancement of genome sequencing procedures.

Diagnostic Advances Through Genome Sequencing

Genome sequencing also allows detailed diagnosis of the organisms and their functions. Advancement in the biotechnological procedures and microbiology studies add to the growth of the global genome sequencing market in the upcoming five years. Procedures like next generation sequencing might be expensive but it provides simultaneous analysis of many genomic loci while revealing the exact sequence changes. For the diagnosis of cancer at early stage and to identify the complication of the chronic disease, the process allows clinicians to test many genes of a cancer simultaneously. The process has multiple advantages like ultra-high throughput, scalability, and speed, thus stimulating further demands and substantiating the market growth. The process is also actively utilized in next generation therapeutics development.

Higher prevalence of genetic mutations and environmental factors that play right into evolving the DNA or RNA of the organisms, require highly capable procedures of sequencing such that advancing and evolving genomes could be mapped. Identification of organisms is not only beneficial in case of diseases, but also to map the variants of species alive, thereby academic growth in the sequencing further facilitates the growth of the global genome sequencing market in the upcoming five years.

Market Segmentation

The global genome sequencing market segmentation is based on nucleotide sequenced, technique, application, end user, regional distribution, and competitive landscape. Based on nucleotide sequenced, the market is differentiated between DNA and RNA. By technique, the market is further segmented into next generation sequencing, PCR, microarray technology, and others. Based on application, the market is bifurcated into diagnostics, drug discovery & development, precision medicine, and others. By end user, the market is fragmented into academic & research institutions, pharmaceutical & biotechnology companies, hospitals & clinics, and others. The market analysis also studies the regional segmentation, divided among Asia-Pacific region, North American region, European region, South American region, and Middle East & African region.

Company Profile

Thermo Fisher Scientific, Inc., Ilumina, Inc., QIAGEN N.V., Eurofins Scientific SE, Agilent Technologies, Inc., Oxford Nanopore Technologies Limited, F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Abbott Laboratories, Inc., Danaher Corporation, are enlisted in a partial list of major market players of the global genome sequencing market.

Years considered for this report:

Historical Years: 2017-2020

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2023-2027

Report Scope:

In this report, global genome sequencing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Genome Sequencing Market, By Nucleotide Sequenced:

DNA

RNA

  • Genome Sequencing Market, By Technique:

Next Generation Sequencing

Polymerase Chain Reaction (PCR)

Microarray Technology

Others

  • Genome Sequencing Market, By Application:

Diagnostics

Drug Discovery & Development

Precision Medicine

Others

  • Genome Sequencing Market, By End User:

Academic & Research Institutions

Pharmaceutical & Biotechnology Companies

Hospitals & Clinics

Others

  • Genome Sequencing Market, By Region:

North America

  • United States
  • Mexico
  • Canada

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia

Europe

  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global genome sequencing market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Genome Sequencing Market

5. Voice of Customer

  • 5.1. Factors Contributing to Demand for Genome Sequencing
  • 5.2. Source of Information
  • 5.3. Commonly Sequenced Nucleotides
  • 5.4. Preference, By Technique
  • 5.5. Demand, By Application
  • 5.6. Brand Awareness

6. Global Genome Sequencing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Nucleotide Sequenced (DNA v/s RNA)
    • 6.2.2. By Technique (Next Generation Sequencing, PCR, Microarray Technology, Others)
    • 6.2.3. By Application (Diagnostics, Drug Discovery & Development, Precision Medicine, Others)
    • 6.2.4. By End User (Academic & Research Institutions, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Others)
    • 6.2.5. By Company (2021)
    • 6.2.6. By Region
  • 6.3. Product Market Map

7. North America Genome Sequencing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Nucleotide Sequenced
    • 7.2.2. By Technique
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Genome Sequencing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Nucleotide Sequenced
        • 7.3.1.2.2. By Technique
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. Mexico Genome Sequencing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Nucleotide Sequenced
        • 7.3.2.2.2. By Technique
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. Canada Genome Sequencing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Nucleotide Sequenced
        • 7.3.3.2.2. By Technique
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User

8. Europe Genome Sequencing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Nucleotide Sequenced
    • 8.2.2. By Technique
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Genome Sequencing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Nucleotide Sequenced
        • 8.3.1.2.2. By Technique
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. Germany Genome Sequencing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Nucleotide Sequenced
        • 8.3.2.2.2. By Technique
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. United Kingdom Genome Sequencing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Nucleotide Sequenced
        • 8.3.3.2.2. By Technique
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. Italy Genome Sequencing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Nucleotide Sequenced
        • 8.3.4.2.2. By Technique
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Spain Genome Sequencing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Nucleotide Sequenced
        • 8.3.5.2.2. By Technique
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. Asia-Pacific Genome Sequencing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Nucleotide Sequenced
    • 9.2.2. By Technique
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Genome Sequencing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Nucleotide Sequenced
        • 9.3.1.2.2. By Technique
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. India Genome Sequencing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Nucleotide Sequenced
        • 9.3.2.2.2. By Technique
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. South Korea Genome Sequencing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Nucleotide Sequenced
        • 9.3.3.2.2. By Technique
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User
    • 9.3.4. Japan Genome Sequencing Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Nucleotide Sequenced
        • 9.3.4.2.2. By Technique
        • 9.3.4.2.3. By Application
        • 9.3.4.2.4. By End User
    • 9.3.5. Australia Genome Sequencing Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Nucleotide Sequenced
        • 9.3.5.2.2. By Technique
        • 9.3.5.2.3. By Application
        • 9.3.5.2.4. By End User

10. South America Genome Sequencing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Nucleotide Sequenced
    • 10.2.2. By Technique
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Genome Sequencing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Nucleotide Sequenced
        • 10.3.1.2.2. By Technique
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Argentina Genome Sequencing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Nucleotide Sequenced
        • 10.3.2.2.2. By Technique
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. Colombia Genome Sequencing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Nucleotide Sequenced
        • 10.3.3.2.2. By Technique
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Middle East and Africa Genome Sequencing Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Nucleotide Sequenced
    • 11.2.2. By Technique
    • 11.2.3. By Application
    • 11.2.4. By End User
    • 11.2.5. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Genome Sequencing Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Nucleotide Sequenced
        • 11.3.1.2.2. By Technique
        • 11.3.1.2.3. By Application
        • 11.3.1.2.4. By End User
    • 11.3.2. Saudi Arabia Genome Sequencing Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Nucleotide Sequenced
        • 11.3.2.2.2. By Technique
        • 11.3.2.2.3. By Application
        • 11.3.2.2.4. By End User
    • 11.3.3. UAE Genome Sequencing Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Nucleotide Sequenced
        • 11.3.3.2.2. By Technique
        • 11.3.3.2.3. By Application
        • 11.3.3.2.4. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Company Profiles
    • 14.1.1. Company Details
    • 14.1.2. Financials (As reported)
    • 14.1.3. Key Market Focus and Geographical Presence
    • 14.1.4. Pricing of Target Products
    • 14.1.5. Market positioning
  • 14.2. Thermo Fisher Scientific, Inc.
  • 14.3. Ilumina, Inc.
  • 14.4. QIAGEN N.V.
  • 14.5. Eurofins Scientific SE
  • 14.6. Agilent Technologies, Inc.
  • 14.7. Oxford Nanopore Technologies Limited
  • 14.8. F. Hoffmann-La Roche AG
  • 14.9. Bio-Rad Laboratories, Inc.
  • 14.10. Abbott Laboratories, Inc.
  • 14.11. Danaher Corporation

15. Strategic Recommendations

(Note: The companies list can be customized based on the client requirements.)